Abarceo Pharma AB
Abarceo Pharma AB is a company in the pharmaceuticals industry founded by Tara Heitner, Claes Wollheim and Albert Salehi.
All edits
Edits on 15 Nov, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
Edits on 6 Sep, 2023
Katrina-Kay Pettitt
Edits made to:
Infobox (+1/-1 properties)
Infobox
Number of Employees (Ranges)
5 – 9
Number of Employees (Ranges)
1 – 4
Edits on 11 Jun, 2022
Golden AI
Edits on 6 Apr, 2022
Ekaterina Suslanova
Edits made to:
Table (+1 rows) (+3 cells) (+72 characters)
Table
Ekaterina Suslanova
Edits made to:
Table (+2 rows) (+4 cells) (+41 characters)
Table
Ekaterina Suslanova
Edits made to:
Table (+1 rows) (+3 cells) (+65 characters)
Table
Edits on 17 May, 2021
Neelam Jhaveri
Edits on 12 May, 2021
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Edits on 8 May, 2021
Gautam Abhishek
Edits made to:
Infobox (+1 properties)
Infobox
Full address
Medeon Science Park, Inkubatorn, Per Albin Hanssons väg 41, Malmö, Sweden 20512, SE
Edits on 22 Apr, 2021
Golden AI
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Edits on 19 Apr, 2021
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Company status
Active
Edits on 8 Apr, 2021
Blessing Nwodo
Edits made to:
Article (+275 characters)
Article
Abarceo is a preclinical stage company, a spinout of Lund University Diabetes Center. The company has expertise in the molecular and genetic causes of beta cell dysfunction in type 2 diabetes and has identified a novel diabetes target responsible for the dysfunction, VDAC-1.
Edits on 31 Mar, 2021
Golden AI
Golden AI
Golden AI
Golden AI
Golden AI
Find more companies like Abarceo Pharma AB
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
